Adding high-dose IV vitamin C to chemotherapy can boost survival for pancreatic cancer patients

  • Post author:
  • Post category:uncategorized

Results from a randomized phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from eight months to 16 months.